Block Listing Application

RNS Number : 3653Y
BB Healthcare Trust PLC
13 January 2022
 

This announcement replaces the Block Listing Application announcement released at 13.49 on 11 January 2022 under RNS 0973Y. The shares to be blocklisted should be 55,176,668, not 56,563,590 as previously stated.  All other details remain unchanged.  The full amended announcement appears below.

 

BB Healthcare Trust plc

 

Block Listing Application

 

The Board of BB Healthcare Trust plc (the "Company") announces that application has been made to the Financial Conduct Authority and to the London Stock Exchange for a block listing of 55,176,668 ordinary shares of one penny each ("Ordinary Shares") in the Company to be admitted to the Official List and to trading on the London Stock Exchange's market for listed securities ("Admission").

 

The above 55,176,668 Ordinary Shares to be block listed may be issued pursuant to the Company's existing authorities to issue new Ordinary Shares on a non pre-emptive basis. These Ordinary Shares may be issued inter alia to satisfy market demand and for the purposes of managing the premium to net asset value (cum income) per Ordinary Share at which the Ordinary Shares are trading. When issued, these Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue. It is expected that Admission will become effective on 14 January 2022.

 

The Company's LEI is: 213800HQ3J3H9YF2UI82

 

For further information please contact:

 

 J.P. Morgan Cazenove

 James Bouverat (Sales)

 Telephone: +44 (0) 207 134 2224

 

 Alvarium Securities Limited

 Mark Thompson  +44 (0)20 7016 6711

 Eddie Nissen     +44 (0)20 7016 6713

 Oliver Kenyon    +44 (0)20 7195 1448

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSBXLFFLFLEBBF
UK 100

Latest directors dealings